期刊文献+

子宫内膜癌组织中酪氨酸蛋白激酶的活性研究 被引量:2

The clinical significance of study on the activity of tyrosine protein kinase in endometrial carcinoma
下载PDF
导出
摘要 目的:通过比较子宫内膜癌、子宫内膜非典型增生及正常子宫内膜组织中蛋白酪氨酸磷酸化水平的差异,以探讨子宫内膜癌发生过程中酪氨酸蛋白激酶(TPK)活性改变的意义。方法:应用免疫组化S-P法测定40例子宫内膜癌、17例子宫内膜非典型增生、28例正常子宫内膜组织中磷酸酪氨酸蛋白(P-Tyr)的表达,从而反映3组中TPK活性水平。结果:在子宫内膜癌、子宫内膜非典型增生及正常子宫内膜组织中P-Tyr阳性表达率分别为75.00%、47.06%、14.29%,3组间差异有显著性(P<0.05)且TPK活性存在显著差异:即子宫内膜癌组高于非典型增生组和正常子宫内膜组。子宫内膜癌组织中,中、低分化组P-Tyr表达明显高于高分化组,差异有显著性(P<0.05)。结论:TPK活性异常是引起子宫内膜异常增生的原因,且与子宫内膜癌病理分化程度相关,而与临床分期、浸润程度及淋巴结转移无关。 Objective: To evaluate the change of tyrosine phosphorylation status in endometrial carcinoma,atypical hyperplasia and normal endometrium, and to explore the significance of the activity of tyrosine protein kinase in the occurrence of endometrial carcinoma.Methods: Using S-P immunohistochemisty method, the expression of phosphotyrosine (P-Tyr) in the specimens of 40 cases with endometrial carcinoma,17 cases with atypical hyperplasia and 28 cases with normal endometrium were examined,thus getting the activity of tyrosine protein kinase in the three groups.Results:The positive immunostaining rate of P-Tyr in cases with endometrial carcinoma, atypical hyperplasia and normal endometrium were 75%, 47.06%, and 14.29% respectively,there was significant difference between cancer tissues, normal endometrium and atypical hyperplasia (P〈0.05),the activity of tyrosine protein kinase in endometrial carcinoma was much higher than that in atypical hyperplasia and normal endometrium.In the endometrial carcinoma,the expression of P-Tyr in moderately-poorly differentiated was significantly higher than that in well differentiated,there was significant difference (P〈0.05).Conclusion:The abnormal activity of tyrosine protein kinase is the cause with endometrium abnormal growth,and correlated with histological grade,but not with clinical stage,muscles invasion, lymphatic gland transfer.
出处 《中国医药导报》 CAS 2008年第14期23-24,共2页 China Medical Herald
关键词 子宫内膜肿瘤 酪氨酸蛋白激酶 磷酸酪氨酸 Endometrial neoplasms Tyrosine protein kinase Phosphotyrosine
  • 相关文献

参考文献8

  • 1[1]Hunter T.Tyrosine phosphorylation:past,present,future[J].Bio-chem Soc Trans,1996,24:308-327.
  • 2裴林,李勇,张光毅,崔肇春,朱正美.脑缺血/再灌对海马磷酸酪氨酸蛋白含量的影响及其机制的研究[J].中国应用生理学杂志,2001,17(1):5-9. 被引量:1
  • 3于士柱,浦佩玉,江德华,安同岭,管欣琴.血小板源生长因子旁分泌效应与胶质瘤间质血管反应性增生的关系[J].中华神经外科杂志,2000,16(3):183-186. 被引量:4
  • 4[4]Cheung TH,Lo KW,Yim SF,et al.Epigenetic and genetic alternation of PTEN in cervical neoplasm[J].Gynecol Oncol,2004,93(3):621-627.
  • 5[5]Di Cristofano A,Pandolfi PP.The multiple roles of PTEN in tumor suppression[J].Cell,2000,100:387-390.
  • 6[6]Gloria P,Peter L,Doris M,et al.Insulin-like growth factor-1 receptor and PTEN protein expression in endometrial carcinoma[J].Am J Clin Pathol,2003,120(1):78-85.
  • 7[7]Zhao M,Bai H,Wang E,et al.Electrical stimulation directly induces preangiogenic reponses in vascular endothelial cell by signaling through VEGF receptors[J].J Cell sci,2004,117(3):397-405.
  • 8[8]Uckun FM,Narla RK Zeren T,et al.In vivo toxicity,pharmacokinetics,and anticancer activity of genistein linked to recombinant human epidermal growth factor[J].Clin Canc Res,1998A:1125-1134.

二级参考文献11

  • 1刘健,张光毅.可溶性和颗粒性Ca^(2+)/CaM PKⅡ对脑缺血与再灌注敏感程度差异性的研究[J].中国应用生理学杂志,1995,11(4):322-325. 被引量:4
  • 2于士柱,中华病理学杂志,1998年,27卷,352页
  • 3Chen C,J Neurochem,1996年,67卷,194页
  • 4Kohr G,J Physiol,1996年,492卷,445页
  • 5Wg Y T,Proc Nat Acad Sci USA,1996年,93卷,1721页
  • 6刘健,中国应用生理学杂志,1995年,11卷,322页
  • 7Hu B R,J Neurochem,1994年,62卷,1357页
  • 8Wang Y T,Nature,1994年,369卷,233页
  • 9Hollnann M,Rev Neurosci,1994年,17卷,31页
  • 10Jean Y,Method in Enzymology,1991年,201卷,53页

共引文献3

同被引文献28

  • 1侯建峰,冯笑山,杨晓鹤,米建强,刑鲁奇,王公平,张广平,高社干,马志坤,郝曙光,段瑞华,陈强,茹艺.大豆异黄酮干预对乳腺癌中ERK1、ERK2和c-Fos表达的影响及意义[J].肿瘤,2010,30(9):744-747. 被引量:8
  • 2白晶,刘先胜,徐永健,谢敏.ERK信号通道调控大鼠气道平滑肌细胞的增殖与凋亡(英文)[J].中国生物化学与分子生物学报,2007,23(1):38-44. 被引量:18
  • 3Mangiola A, Lama G, Giannitelli C, et al. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme : Possible prognostic implications [ J ]. Clin Cancer Res, 2007, 13(23): 6970-6977.
  • 4张丰,李楠.ERK/MAPK信号传导途径在乳腺肿瘤治疗中的意义[J].中国肿瘤生物治疗杂志,2007,14(5):497-500. 被引量:15
  • 5Ward MH,Colt JS,Deziel NC,et al.Residential levels of polybrominated diphenyl ethers and risk of childhood acute lymphoblastic leukemia in California.Environ Health Perspect,2014;[Epub ahead of print].
  • 6Wang Q,Wang Y,Fritz D,et al.Interactions of the protein-tyrosine phosphatase-αwith the focal adhesion targeting domain of focal adhesion kinase are involved in IL-1 signaling in fibroblasts.J Biol Chem,2014;289(26):18427-18441.
  • 7Kim JH,Kwon J,Lee HW,et al.Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer.Oncol Rep,2014;31(6):2708-2712.
  • 8Jin J,Ryu HS,Lee KB,et al.High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.PLoS One,2014;9(2):e90247.
  • 9Arnaoaut HH,Mokhtar DA,Samy RM,et al.CDX2 gene expression in acute lymphoblastic leukemia.J Egypt Natl Canc Inst,2014;26(2):55-59.
  • 10Kondoh T,Kuribayashi K,Tanaka M,et al.CD7 promotes extramedullary involvement of the B-cell acute lymphoblastic leukemia line Tanoue by enhancing integrin beta2-dependent cell adhesiveness.Int J Oncol,2014;45(3):1073-1081.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部